IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 276-300 out of 1334.

<< < 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 > >>

Public Release: 24-Mar-2015
Brain tumor cells decimated by mitochondrial 'smart bomb'
An experimental drug that attacks brain tumor tissue by crippling the cells' energy source called the mitochondria has passed early tests in animal models and human tissue cultures, say Houston Methodist scientists.
Donna and Kenneth Peak Foundation, Houston Methodist Hospital/Kenneth Peak Brain and Pituitary Center, Taub Foundation, Pauline Sterne Wolff Memorial Foundation/Blanche Green Estate Fund, Verelan Foundation, and others

Contact: Gale Smith
Houston Methodist

Public Release: 24-Mar-2015
Concerns over the online market of human breast milk
The sale of human breast milk on the internet poses serious risks to infant health and needs urgent regulation, argue experts in The BMJ today.

Contact: Gozde Zorlu

Public Release: 24-Mar-2015
New technique paints tissue samples with light
One infrared scan can give pathologists a window into the structures and molecules inside tissues and cells, enabling fast and broad diagnostic assessments, thanks to an imaging technique developed by University of Illinois researchers and clinical partners. Using a combination of advanced microscope imaging and computer analysis, the new technique can give pathologists and researchers precise information without using chemical stains or dyes.
National Institutes of Health

Contact: Liz Ahlberg
University of Illinois at Urbana-Champaign

Public Release: 24-Mar-2015
Gynecologic Oncology
Could a tampon one day help predict endometrial cancer? Mayo Clinic researchers say yes
Researchers at Mayo Clinic have shown that it is possible to detect endometrial cancer using tumor DNA picked up by ordinary tampons. The new approach specifically examines DNA samples from vaginal secretions for the presence of chemical 'off' switches -- known as methylation -- that can disable genes that normally keep cancer in check.
Mayo Clinic Specialized Program of Research Excellence (SPORE) in Ovarian Cancer from the National Institutes of Health, the Office of Women's Health Research Building Interdisciplinary Careers in Women's Health (BIRCWH), Mayo Clinic's NCI Cancer Center S

Contact: Joe Dangor
Mayo Clinic

Public Release: 24-Mar-2015
Cancer patients want more information about medical imaging risk
A substantial gap exists between patient expectations and current practices for providing information about medical imaging tests that use radiation, according to a new study. Researchers said the findings highlight a need for better communication as medicine enters an era of patient-centered care.

Contact: Linda Brooks
Radiological Society of North America

Public Release: 24-Mar-2015
Breast Cancer Research and Treatment
Women with diabetes more likely to be diagnosed with advanced stage breast cancer
Diabetes is associated with more advanced stage breast cancer, according to a new study by the Institute for Clinical Evaluative Sciences and Women's College Hospital. The findings, published today in the journal Breast Cancer Research and Treatment, confirm a strong link between diabetes and later stage breast cancer at diagnosis for Canadian women.
Canadian Institutes for Health Research, Ontario Institute for Cancer Research

Contact: Diba Kohandani
416-323-6400 x3156
Women's College Hospital

Public Release: 24-Mar-2015
Chemical tag marks future microRNAs for processing, study shows
By adding a chemical group to a particular sequence on RNA molecules, cells appear able to label the molecules that should be trimmed to make microRNAs. Because microRNAs help control processes throughout the body, this discovery has wide-ranging implications for development, health and disease, including cancer, the entry point for this research.

Contact: Wynne Parry
Rockefeller University

Public Release: 24-Mar-2015
British Journal of Cancer
A cancer research breakthrough
Queen's University cancer researcher Madhuri Koti has discovered a biomarker that will help lead to better predictions of the success of chemotherapy in ovarian cancer patients. This discovery could lead to better treatment options in the fight against ovarian cancer.

Contact: Anne Craig
Queen's University

Public Release: 23-Mar-2015
Journal of Clinical Oncology
Detecting cancer cells in blood can give an early warning of treatment failure
A blood test that measures the number of cells shed from prostate tumors into the bloodstream can act as an early warning sign that treatment is not working, a major new study shows. Researchers showed that measuring the numbers of circulating tumor cells in the blood predicted which men were benefiting least from a prostate cancer drug after as little as 12 weeks of treatment.
Medical Research Council, Janssen Diagnostics, Prostate Cancer Foundation, Prostate Cancer UK

Contact: Claire Hastings
Institute of Cancer Research

Public Release: 23-Mar-2015
Stress management techniques improve long-term mood and quality of life
A new study shows that providing women with skills to manage stress early in their breast cancer treatment can improve their mood and quality of life many years later.

Contact: Megan Ondrizek
University of Miami

Public Release: 23-Mar-2015
International Journal of Radiation Oncology, Biology and Physics
Sweeping prostate cancer review upends widely held belief on radiation after surgery
Two new studies have upended the widely held view that it's best to delay radiation treatment as long as possible after the removal of the prostate in order to prevent unwanted side effects.
Prostate Cancer Foundation

Contact: Josh Barney
University of Virginia Health System

Public Release: 23-Mar-2015
Stress management techniques improve long-term mood and quality of life
A new study shows that providing women with skills to manage stress early in their breast cancer treatment can improve their mood and quality of life many years later.

Contact: Evelyn Martinez

Public Release: 23-Mar-2015
Journal of Clinical Investigation
Metabolic compensation underlies drug resistance in glioblastoma
A new study in the Journal of Clinical Investigation indicates that mTOR inhibitor resistance in gliobalstoma is likely the result of compensatory glutamine metabolism.
Takeda Science Foundation, Ludwig Institute for Cancer Research, NIH/National Institute for Neurological Diseases and Stroke, NIH/National Cancer Institute, Ben and Catherine Ivy Foundation, Defeat GBM Research Collaboration

Contact: Corinne Williams
Journal of Clinical Investigation

Public Release: 23-Mar-2015
BMC Medicine
Good news for serial cereal eaters
A diet high in whole grains and cereal fibers is associated with a reduced risk of premature death, according to research published in the open-access journal BMC Medicine. The results also show cereal fibers to be associated with reduced risk of deaths in varying degrees for chronic diseases including cancer, heart disease, respiratory disease and diabetes.

Contact: Shane Canning
BioMed Central

Public Release: 23-Mar-2015
Journal of Cell Biology
Stress granules ease the way for cancer metastasis
Tumors that produce more stress granules are more likely to metastasize, according to researchers in Canada. The results suggest that drugs to inhibit the formation of these structures might rein in cancer metastasis.
Terry Fox Research Institute, Prostate Cancer Canada-Movember Foundation, German Research Foundation, British Columbia Cancer Foundation

Contact: Rita Sullivan King
Rockefeller University Press

Public Release: 23-Mar-2015
Nature Medicine
Combination therapy boosts antiviral response to chronic infection
A Yale-led team has identified a promising new combination immunotherapy to enhance the body's ability to fight chronic viral infections and possibly cancer.
Yale Medical Scientist Training Program, and Howard Hughes Medical Institute

Contact: Ziba Kashef
Yale University

Public Release: 23-Mar-2015
TSRI team discovers enzyme that keeps blood stem cells functional to prevent anemia
When stem cells become too active and divide too often, they risk acquiring cell damage and mutations. In the case of blood stem cells (also called HSCs), this can lead to blood cancers, a loss of blood cells and an impaired ability to fight disease. Scientists at The Scripps Research Institute have found that a particular enzyme in HSCs is key to maintaining healthy periods of inactivity.
National Institutes of Health, Leukemia and Lymphoma Society, California Institute for Regenerative Medicine, Deutsche Forschungsgemeinschaft

Contact: Madeline McCurry-Schmidt
Scripps Research Institute

Public Release: 23-Mar-2015
Nature Immunology
Experiments reveal key components of the body's machinery for battling deadly tularemia
Research led by scientists at St. Jude Children's Research Hospital has identified key molecules that trigger the immune system to launch an attack on the bacterium that causes tularemia. The research was published online March 16 in Nature Immunology.
National Institutes of Health, ALSAC

Contact: Carrie Strehlau
St. Jude Children's Research Hospital

Public Release: 23-Mar-2015
Journal of the National Cancer Institute
New insights into survival outcomes of Asian-Americans diagnosed with cancer
Numerous studies have documented racial differences in deaths from cancer among non-Hispanic whites and African-Americans, but little has been known about survival outcomes for Asian-Americans who have been diagnosed with cancer, until now. A new study from Brigham and Women's Hospital examined cancer patients in eight different Asian-American subgroups and found their cancer-specific mortality was substantially lower than that of non-Hispanic white patients.
Vattikuti Urology Institute, Brigham and Women's Hospital/Professor Walter Morris-Hale Distinguished Chair in Urologic Oncology

Contact: Haley Bridger
Brigham and Women's Hospital

Public Release: 23-Mar-2015
How our DNA may prevent bowel cancer
A new study published in the prestigious Journal of the American Medical Association suggests the link between aspirin and colon cancer prevention may depend on a person's individual genetics.

Contact: Anne Rahilly
University of Melbourne

Public Release: 23-Mar-2015
Cancer Prevention Research
Metformin and vitamin D3 show impressive promise in preventing colorectal cancer
The concept was simple: if two compounds each individually show promise in preventing colon cancer, surely it's worth trying the two together to see if even greater impact is possible. Not only did the combination of the two improve outcomes in animal studies, but the dual-compound effect was dramatically better than either option alone. Their findings served as the cover feature February's edition of Cancer Prevention Research.
NIH/National Cancer Institute

Contact: Jeannette Spalding
Case Western Reserve University

Public Release: 23-Mar-2015
American Journal of Managed Care
Implementing decision aids affects care decisions in urology
After Group Health Cooperative implemented video-based decision aids for men with two common prostate conditions, rates of elective surgery for benign prostatic hyperplasia and rates of active treatment for localized prostate cancer declined over six months. But the total cost of health care for those patients did not fall significantly.
Commonwealth Fund, Informed Medical Decisions Foundation, Group Health Foundation, Health Dialog

Contact: Rebecca Hughes
Group Health Research Institute

Public Release: 23-Mar-2015
Journal of Sexual Medicine
Exercise linked to improved erectile and sexual function in men
Men who exercise more have better erectile and sexual function, regardless of race, according to a recent study published in the Journal of Sexual Medicine. While past studies have highlighted the relationship between better erectile function and exercise, African-American men have been underrepresented in this literature.

Contact: Cara Martinez
Cedars-Sinai Medical Center

Public Release: 23-Mar-2015
Journal of Clinical Investigation
Combining the old and new to kill cancer cells
A team of Singapore based scientists have found that pairing a new approach with an old drug may be an effective approach to treat common cancers. In a landmark study, professor David Virshup and Dr. Jit Kong Cheong, from Duke-NUS Graduate Medical School Singapore, identified a new signalling pathway that regulates the internal diet of cancers.
Singapore Ministry of Health's National Medical Research Council

Contact: Dharshini Subbiah
Duke-NUS Graduate Medical School Singapore

Public Release: 23-Mar-2015
Journal of Clinical Oncology
How to get smarter on pills for seniors
Cancer patients over the age of 65 often take multiple drugs, which can interfere with cancer treatment. A new study shows that currently used tools to prevent over-medicating senior cancer patients need improvement.

Contact: Edyta Zielinska
Thomas Jefferson University

Showing releases 276-300 out of 1334.

<< < 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 > >>

  Search News Releases


Featured Multimedia